Biblio

Export 3139 results:
Author Title [ Type(Desc)] Year
Journal Article
F. Guillot, Kemppainen, S., Lavasseur, G., Miettinen, P. O., Laroche, S., Tanila, H., and Davis, S., “Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AβPP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1157-73, 2016.
A. Zhu, Wu, Z., Zhong, X., Ni, J., Li, Y., Meng, J., Du, C., Zhao, X., Nakanishi, H., and Wu, S., “Brazilian Green Propolis Prevents Cognitive Decline into Mild Cognitive Impairment in Elderly People Living at High Altitude.”, J Alzheimers Dis, vol. 63, no. 2, pp. 551-560, 2018.
E. L. Goldwaser, Acharya, N. K., Sarkar, A., Godsey, G., and Nagele, R. G., “Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 2, pp. 445-56, 2016.
H. - F. Wang, Wan, Y., Hao, X. - K., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Tan, L., Zhang, D. - Q., Tan, L., and Yu, J. - T., “Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration.”, J Alzheimers Dis, vol. 52, no. 1, pp. 179-90, 2016.
R. E. Curiel, Crocco, E., Rosado, M., Duara, R., Greig, M. T., Raffo, A., and Loewenstein, D. A., “A Brief Computerized Paired Associate Test for the Detection of Mild Cognitive Impairment in Community-Dwelling Older Adults.”, J Alzheimers Dis, vol. 54, no. 2, pp. 793-9, 2016.
H. Li, Luo, X. - B., Xu, Y., and Hou, X. - Y., “A Brief Ischemic Postconditioning Protects Against Amyloid-β Peptide Neurotoxicity by Downregulating MLK3-MKK3/6-P38MAPK Signal in Rat Hippocampus.”, J Alzheimers Dis, vol. 71, no. 2, pp. 671-684, 2019.
S. Gourmaud, Thomas, P., Thomasseau, S., Tible, M., Abadie, C., Paquet, C., and Hugon, J., “Brimapitide Reduced Neuronal Stress Markers and Cognitive Deficits in 5XFAD Transgenic Mice.”, J Alzheimers Dis, vol. 63, no. 2, pp. 665-674, 2018.
I. A. Clark and Vissel, B., “Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.”, J Alzheimers Dis, vol. 79, no. 3, pp. 931-948, 2021.
T. J. Nelson, Sun, M. - K., Lim, C., Sen, A., Khan, T., Chirila, F. V., and Alkon, D. L., “Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer's Disease Phase IIa and Expanded Access Trials.”, J Alzheimers Dis, vol. 58, no. 2, pp. 521-535, 2017.
W. R. Leifert, Nguyen, T., Rembach, A., Martins, R., Rainey-Smith, S., Masters, C. L., Ames, D., Rowe, C. C., S Macaulay, L., François, M., and Fenech, M. F., “Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 48, no. 2, pp. 443-52, 2015.
R. Benca, W Herring, J., Khandker, R., and Qureshi, Z. P., “Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer's Disease: A Structured Literature Review.”, J Alzheimers Dis, vol. 86, no. 1, pp. 83-109, 2022.
L. De Beaumont, Pelleieux, S., Lamarre-Théroux, L., Dea, D., and Poirier, J., “Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.”, J Alzheimers Dis, vol. 54, no. 3, pp. 913-922, 2016.
A. R. Haeusler, Donnelly, C. J., Periz, G., Simko, E. A. J., Shaw, P. G., Kim, M. - S., Maragakis, N. J., Troncoso, J. C., Pandey, A., Sattler, R., Rothstein, J. D., and Wang, J., “C9orf72 nucleotide repeat structures initiate molecular cascades of disease.”, Nature, vol. 507, no. 7491, pp. 195-200, 2014.
P. Maresova, Dolejš, J., and Kuca, K., “Call for a Uniform Strategy of Collecting Alzheimer's Disease Costs: A Review and Meta-Analysis.”, J Alzheimers Dis, vol. 63, no. 1, pp. 227-238, 2018.
J. Gu, Jin, N., Ma, D., Chu, D., Iqbal, K., Gong, C. - X., and Liu, F., “Calpain I Activation Causes GLUT3 Proteolysis and Downregulation of O-GlcNAcylation in Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1737-1746, 2018.
F. P. M. Oliveira, Moreira, A. Paula, de Mendonça, A., Verdelho, A., Xavier, C., Barroca, D., Rio, J., Cardoso, E., Cruz, Â., Abrunhosa, A., and Castelo-Branco, M., “Can 11C-PiB-PET Relative Delivery R1 or 11C-PiB-PET Perfusion Replace 18F-FDG-PET in the Assessment of Brain Neurodegeneration?”, J Alzheimers Dis, vol. 65, no. 1, pp. 89-97, 2018.
I. Lazarou, Adam, K., Georgiadis, K., Tsolaki, A., Nikolopoulos, S., Kompatsiaris, I. Yiannis, and Tsolaki, M., “Can a Novel High-Density EEG Approach Disentangle the Differences of Visual Event Related Potential (N170), Elicited by Negative Facial Stimuli, in People with Subjective Cognitive Impairment?”, J Alzheimers Dis, vol. 65, no. 2, pp. 543-575, 2018.
A. Harding, Robinson, S., Crean, S. J., and Singhrao, S. K., “Can Better Management of Periodontal Disease Delay the Onset and Progression of Alzheimer's Disease?”, J Alzheimers Dis, vol. 58, no. 2, pp. 337-348, 2017.
H. Wang, Wang, G., Billings, R., Li, D., Haase, S. R., Wheeler, P. F., Vance, D. E., and Li, W., “Can Diet Supplements of Macular Pigment of Lutein, Zeaxanthin, and Meso-zeaxanthin Affect Cognition?”, J Alzheimers Dis, vol. 87, no. 3, pp. 1079-1087, 2022.
E. Pongan, Tillmann, B., Leveque, Y., Trombert, B., Getenet, J. Claude, Auguste, N., Dauphinot, V., Haouari, H. El, Navez, M., Dorey, J. - M., Krolak-Salmon, P., Laurent, B., and Rouch, I., “Can Musical or Painting Interventions Improve Chronic Pain, Mood, Quality of Life, and Cognition in Patients with Mild Alzheimer's Disease? Evidence from a Randomized Controlled Trial.”, J Alzheimers Dis, vol. 60, no. 2, pp. 663-677, 2017.
T. Mendes, Cardoso, S., Guerreiro, M., Maroco, J., Silva, D., Alves, L., Schmand, B., Gerardo, B., Lima, M., Santana, I., and de Mendonça, A., “Can Subjective Memory Complaints Identify Aβ Positive and Aβ Negative Amnestic Mild Cognitive Impairment Patients?”, J Alzheimers Dis, vol. 70, no. 4, pp. 1103-1111, 2019.
F. Emanuele Pozzi, Appollonio, I., Ferrarese, C., and Tremolizzo, L., “Can Traditional Board Games Prevent or Slow Down Cognitive Impairment? A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 95, no. 3, pp. 829-845, 2023.
C. Lachner, Day, G. S., Camsari, G. Balci, Kouri, N., Ertekin-Taner, N., Boeve, B. F., Labuzan, S. A., Lucas, J. A., E Thompson, A., Siddiqui, H., Crook, J. E., Cabrera-Rodriguez, J. N., Josephs, K. A., Petersen, R. C., Dickson, D. W., R Reichard, R., Mielke, M. M., Knopman, D. S., Graff-Radford, N. R., and Murray, M. E., “Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old.”, J Alzheimers Dis, vol. 90, no. 1, pp. 405-417, 2022.
H. Khodadadi, Salles, É. Lopes, Jarrahi, A., Costigliola, V., Khan, M. B., Yu, J. C., Morgan, J. C., Hess, D. C., Vaibhav, K., Dhandapani, K. M., and Baban, B., “Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 80, no. 3, pp. 973-977, 2021.
E. Aso, Andrés-Benito, P., Carmona, M., Maldonado, R., and Ferrer, I., “Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.”, J Alzheimers Dis, vol. 51, no. 2, pp. 489-500, 2016.

Pages